| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Neuronetics, Inc. (STIM) has 10 insiders with recent SEC Form 4 filings, including 2 buys and 0 sells. STIM is classified in the Health Care Equipment & Supplies industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 10.55M | $12.66M | - | |
| CEO | 1.57M | $1.88M | - | |
| Dir | 1.51M | $1.82M | - | |
| 10% | 1.44M | $1.72M | - | |
| VP | 879.5K | $1.06M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jul 2, 2018 | Campe Stephen M | Director | Buy | 10,000 | $17.00 | $170,000.00 | New | |
| Jul 2, 2018 | Guthrie Daniel | Chief Commercial Officer | Buy | 1,500 | $17.00 | $25,500.00 | +3.7% |